Anupam Rasayan buys 48.2% stake in Bliss GVS for ₹1,750 cr
In short
Anupam Rasayan India Limited bought 48.2% of Bliss GVS Pharma for ₹1,750 crore. The deal was done through a promoter share purchase agreement at ₹299 per share, plus an open offer and a small market top-up.
The purchase gives Anupam Rasayan a major stake in the company. The report does not say if all closing steps are finished or if any approvals are still pending.
What the reporting says
Anupam Rasayan India Limited completed the purchase of a 48.2% stake in Bliss GVS Pharma for ₹1,750 crore, according to the publisher summary. The stake was acquired through the promoter and share purchase agreement route at ₹299 per share, with an open offer and a small on-market top-up. The reporting does not state whether the full controlling interest is already closed or whether any remaining conditions apply.
Why it matters
Anupam Rasayan India Limited completed purchase of a 48.2% stake in Bliss GVS Pharma for ₹1,750 crore, according to the summary. The deal structure included a promoter share purchase agreement at ₹299 per share, plus an open offer and a small on-market top-up. The move is significant for Anupam Rasayan’s ownership position, but the reporting does not state whether any further regulatory or closing steps remain.